Professional background
Since 2025 Head of the asthma hospitalization unit, University hospital of Bordeaux (CHU)
Since 2024 Head of the Lung Function Testing department, University hospital of Bordeaux (CHU)
Since 2022 Director of the Cardio-Thoracic Research Center of Bordeaux (CRCTB, INSERM U1045), University of Bordeaux
Since 2011 Director of the Bronchial Remodeling team (CRCTB, INSERM U1045), University of Bordeaux
Since 2008 Professor of Physiology (University of Bordeaux), pulmonologist hospital practitioner (CHU)
Funding
ANR international PRC (2024-2028)
AstraZeneca unrestricted grant (2021-2023)
AST Prematuration grant (2021-2024)
FRM Team (2017-2020)
Patents
1. Berger P, Dupin I, Girodet PO.
Patent filed on January 28, 2015 under serial number EP No. 15152886.6 with the European Patent Office: New compositions and methods of treating and/or preventing Chronic Obstructive Pulmonary Disease.
PCT filed on January 28, 2016 (PCT/EP2016/051771) for the USA, Canada, Australia, BRIC countries, Israel, Japan, and Eurasia.
Patent granted on 10/09/2019 under serial number EP No. 3050574: Use of plerixafor for treating and/or preventing acute exacerbations of chronic obstructive pulmonary disease.
International publication on August 4, 2016 under No. WO/2016/120369A1.
License signed on July 26, 2025 with 4 Living Biotech.
2. Dournes G, Baldacci F, Laurent F, Berger P.
French patent filed on May 27, 2016 under serial number 22605-FR with the French Patent Office: Process for the geometric characterization of lung airways by MRI.
European extension filed on May 29, 2017 with the European Patent Office: MRI Method for the geometrical characterization of pulmonary airways (No. 17726309.2; No. 16/304,574), granted on July 5, 2019.
US extension filed on May 29, 2017 and granted under US No. 11,361,429 B2 on June 14, 2022.
International publication on November 30, 2017 under No. WO/2017/203064A1.
3. Dournes G, Benlala I, Laurent F, Berger P.
French patent filed on July 31, 2019 under serial number 1908734-FR with the French Patent Office: Method for generating a biomarker system.
PCT filed on June 3, 2020 (PCT/EP2020/065380) with the European Patent Office: Method for generating a biomarker system.
Patent granted on February 4, 2021 under No. 3099621.
International publication on February 4, 2021 under No. WO/2021/018439A1.
4. Berger P, Dupin I, Prevel R, James C, Girodet PO, Bismuth K, Rattenbach R.
Patent filed on May 7, 2020 under serial number EP No. 20173595.8 with the European Patent Office (under examination): New compositions and methods of treating COVID-19 Disease.
License agreement signed by 4-Living Biotech on July 16, 2021.
International publication on November 11, 2021 under No. WO/2021/224356.
5. Rattenbach R, Breton J, Chéron V, Prevel R, Berger P.
CXCR4 inhibitor compound in the treatment and/or prevention of severe ARDS.
License signed on July 26, 2025 with 4 Living Biotech.
International publication on October 2, 2025 under No. WO/2025/202445.